(1-aza-bicyclo[3.3.1] non4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amin es as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders

Details for Australian Patent Application No. 2006326257 (hide)

Owner Novartis AG

Inventors Feuerbach, Dominik; Koller, Manuel; Hurth, Konstanze; Frederiksen, Mathias; Roy, Bernard Lucien

Agent Davies Collison Cave

Pub. Number AU-B-2006326257

PCT Pub. Number WO2007/068475

Priority 0525673.0 16.12.05 GB

Filing date 14 December 2006

Wipo publication date 21 June 2007

Acceptance publication date 16 June 2011

International Classifications

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/068475 Priority application(s): WO2007/068475

2 October 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read (1-aza-bicyclo[3.3.1] non4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders

16 June 2011 Application Accepted

  Published as AU-B-2006326257

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006326258-[ (1Hindol5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenrative disorders.

2006326256-(2,5-dioxoimidazolidin-I-yl)-N-hydroxy-a cetamides as metalloproteinase inhibitors